Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Conjugate Group was founded in 2017 and positions itself as a “Flexible Drug Development” partner for emerging biotech companies. According to its website, it is not a typical SaaS or enterprise software platform, but a provider of drug development consulting, contract staffing, functional outsourcing, and integrated team services. It helps clients reduce project risk across clinical development, regulatory submissions, medical writing, quality compliance, and related areas.
Its services are divided into three categories: Individual Resources, which brings in individual consultants or contract staff for short-term deliverables, expert backfilling, or staffing gaps; Functional Outsourcing, where an entire functional group—such as clinical operations, regulatory affairs, or medical writing—is outsourced to Conjugate, with Conjugate responsible for team structure, communication processes, and day-to-day coordination; and Fully Integrated Teams, designed for more complex projects by building multifunctional teams based on client needs. Covered areas include biostatistics, CMC, DMPK/BIOA, medical affairs, project management, quality engineering, safety and pharmacovigilance, validation, and more, spanning pre-IND, Phase 1–4, NDA/BLA/MAA, and other development stages.
The website does not disclose fixed packages, pricing, payment methods, or contract terms. Its business model is clearly based on customized service quotes, emphasizing the ability to flexibly scale resources up or down according to client budgets, timelines, and workload, supporting both short-term delivery-based projects and ongoing functional support.
Its strengths lie in its strong industry focus, making it well suited to drug development scenarios that are highly specialized and carry significant milestone risk. Case examples indicate involvement in NDA medical writing, IND submissions, and the setup of multifunctional expert teams. The downside is that information about software capabilities is almost nonexistent: there is no visible mention of APIs, third-party integrations, cloud deployment, self-hosting, permission systems, or other key SaaS features. Data security and compliance certifications are also not disclosed in detail.
It is better suited for biotech companies with limited staffing that are rapidly advancing through IND, clinical, or NDA stages, as well as pharmaceutical companies looking to strengthen a specific function through an FSP model. It is not suitable for users seeking standardized enterprise software, project management SaaS, or a self-service purchasable platform.
Based solely on the crawled text, its accessibility in mainland China cannot be determined and is marked as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on conjugategroup.com official site.
conjugategroup.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach conjugategroup.com directly.